The chips are down
Abstract
Geneticists' desire to track the roots of complex diseases has shaken up the market for gene chips. Meredith Wadman reports on two firms jostling for position in a business potentially worth US$500 million.
- Publication:
-
Nature
- Pub Date:
- November 2006
- DOI:
- 10.1038/444256a
- Bibcode:
- 2006Natur.444..256.